NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center has participated in 312 clinical trials with 196 currently active.
Therapeutic areas: Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant.
Sponsors: National Cancer Institute (NCI), Children's Oncology Group, NRG Oncology.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center has 312 clinical trials on record, with 196 currently active. Their work covers Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant.
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.